

Glycaemia, Beta-Cell Function, and Incretin Hormones Post-OGTT One Year after Gastric Bypass and Sleeve Gastrectomy in Patients with Morbid Obesity and Type 2 Diabetes: An RCT (Oseberg Study)
In this medfyle
Expert Commentary by Prof. Tatjana Milenkovic, MD
This Medfyle was published more than two years ago. More recent Medfyle on this topic may now be available.
Acknowledgements
This is a highlights summary of an oral session given at the ADA 2020 - 80th Scientific Sessions and presented by:
Farhat Fatima, MD
Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway
The content is produced by Infomedica, the official reporting partner of ADA 2020 Virtual Meeting. The summary text was drafted by Patrick Moore, PhD, and reviewed by Marco Gallo, MD, an independent external expert, and approved by Dana M. Dabelea, MD, PhD, the scientific editor of the program.The presenting authors of the original session had no part in the creation of this conference highlights summary.
In addition, an expert commentary on the topic has been provided by:
About the Expert

Prof. Tatjana Milenkovic is a professor of internal medicine at the University “St Cyril and Methodius”, Medical Faculty in Skopje, Macedonia. She works at the Clinic of Endocrinology, Diabetes and Metabolic Diseases since 1985, where in 1995 she has established the Department of education of people with diabetes – and she has been Head of the department ever since. She is a member of the Executive Committee of Diabetes Education Study group (DESG). She is the President of Macedonian Diabetes Association, since 2013, the President of the Macedonian Scientific Association of endocrinologists and diabetologists since 2014 and member of IDF Europe board for biennium 2020-2021.
References
1. Hofso D, Fatima F, Borgerass H, et al. Gastric Bypass Versus Sleeve Gastrectomy in Patients With Type 2 Diabetes (Oseberg): A Single-Centre, Triple-Blind, Randomised Controlled Trial. Lancet Diabetes Endocrinol. 2019;7(12):912-924.